JavaScript scheint in Ihrem Browser deaktiviert zu sein. Sie müssen JavaScript in Ihrem Browser aktivieren, um alle Funktionen in diesem Shop nutzen zu können.
Acute myeloid leukemia, myelodysplastic syndrome
Established at diagnosis of a 68-year-old male with acute myeloid leukemia (AML M6) secondary to myelodysplastic syndrome (MDS, subtype refractory anemia with excess of blasts, RAEB) in 1989; cells were described to be proliferatively responsive to GM-CSF and IL-3. Cells have been shown to synthesize haemoglobin when GM-CSF or IL-3 is substituted by erythropoietin (Epo). They have been reported to be positive for leukocyte common antigen (CD45) and some multilineage markers such as CD13, CD33 and CD34, but are negative for T- and B-cell antigens and mature myelomonocytic antigens. Due to their reaction with some monoclonal antibodies recognising erythroid and platelet glycoproteins it has been suggested that F-36P has a multilineage phenotype.
Homo sapiens Tissue:Pleural effusion Morphology:Lymphoblastoid Properties: Polymorph cells growing as adherent cells and singly in suspension Cytogenic data: human flat-moded hypodiploid karyotype with 6% polyploidy - 41(40-43)< 2n> XY, -3, -13, -16, -19, -21, -22, +2mar, ins(X; 13)(p11; q?q?), del(3)(p13p24), add(5)(q11), dup(5)(q11q35), der(6)add(6)(p23)dup(6)(q25q27), der(7)add(7)(p13)add(7)(q12), add(9)(q35), der(9)del(9)(q11q34)inv(9)(p2?4; q34), der(10)t(8; 10)(q24; p14)t(10; 7)(q25; q12), del(11)(q14q21), der(21)t(10; 21)(p14; p12) - sideline with dup(1)(p35p36), dup(2)(q1?q2?), del(3)(p13p24) - matches published karyotype Patient: Male, 68 yrs of age Medium: RPMI-1640 Medium + 20% FBS + 10 ng/mL GM-CSF or 5 ng/mL rh IL-3 Subculture:Subculture saturated culture 1:3 to 1:8 every 2-5 days; seed out at ca. 0.3-0.5 x 10^6 cells/ml; maintain at ca. 1.0 x 10^6 cells/ml; maximum density at ca. 1.8 x 10^6 cells/ml. Upon cytokine withdrawal cells do not die but undergo a stationary survival status. REMARKS: by favoring selective growth, suboptimal culture of cytokine-dependent cell lines may promote growth of factor-independent subclones. Selective conditions include cytokine insufficiency and inadequate cell density. Therefore, we cannot guarantee indefinite stability of factor-dependence of cell lines. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 7.5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
Pleural effusion Morphology:Lymphoblastoid Properties: Polymorph cells growing as adherent cells and singly in suspension Cytogenic data: human flat-moded hypodiploid karyotype with 6% polyploidy - 41(40-43)< 2n> XY, -3, -13, -16, -19, -21, -22, +2mar, ins(X; 13)(p11; q?q?), del(3)(p13p24), add(5)(q11), dup(5)(q11q35), der(6)add(6)(p23)dup(6)(q25q27), der(7)add(7)(p13)add(7)(q12), add(9)(q35), der(9)del(9)(q11q34)inv(9)(p2?4; q34), der(10)t(8; 10)(q24; p14)t(10; 7)(q25; q12), del(11)(q14q21), der(21)t(10; 21)(p14; p12) - sideline with dup(1)(p35p36), dup(2)(q1?q2?), del(3)(p13p24) - matches published karyotype Patient: Male, 68 yrs of age Medium: RPMI-1640 Medium + 20% FBS + 10 ng/mL GM-CSF or 5 ng/mL rh IL-3 Subculture:Subculture saturated culture 1:3 to 1:8 every 2-5 days; seed out at ca. 0.3-0.5 x 10^6 cells/ml; maintain at ca. 1.0 x 10^6 cells/ml; maximum density at ca. 1.8 x 10^6 cells/ml. Upon cytokine withdrawal cells do not die but undergo a stationary survival status. REMARKS: by favoring selective growth, suboptimal culture of cytokine-dependent cell lines may promote growth of factor-independent subclones. Selective conditions include cytokine insufficiency and inadequate cell density. Therefore, we cannot guarantee indefinite stability of factor-dependence of cell lines. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 7.5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
Lymphoblastoid Properties: Polymorph cells growing as adherent cells and singly in suspension Cytogenic data: human flat-moded hypodiploid karyotype with 6% polyploidy - 41(40-43)< 2n> XY, -3, -13, -16, -19, -21, -22, +2mar, ins(X; 13)(p11; q?q?), del(3)(p13p24), add(5)(q11), dup(5)(q11q35), der(6)add(6)(p23)dup(6)(q25q27), der(7)add(7)(p13)add(7)(q12), add(9)(q35), der(9)del(9)(q11q34)inv(9)(p2?4; q34), der(10)t(8; 10)(q24; p14)t(10; 7)(q25; q12), del(11)(q14q21), der(21)t(10; 21)(p14; p12) - sideline with dup(1)(p35p36), dup(2)(q1?q2?), del(3)(p13p24) - matches published karyotype Patient: Male, 68 yrs of age Medium: RPMI-1640 Medium + 20% FBS + 10 ng/mL GM-CSF or 5 ng/mL rh IL-3 Subculture:Subculture saturated culture 1:3 to 1:8 every 2-5 days; seed out at ca. 0.3-0.5 x 10^6 cells/ml; maintain at ca. 1.0 x 10^6 cells/ml; maximum density at ca. 1.8 x 10^6 cells/ml. Upon cytokine withdrawal cells do not die but undergo a stationary survival status. REMARKS: by favoring selective growth, suboptimal culture of cytokine-dependent cell lines may promote growth of factor-independent subclones. Selective conditions include cytokine insufficiency and inadequate cell density. Therefore, we cannot guarantee indefinite stability of factor-dependence of cell lines. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 7.5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
Polymorph cells growing as adherent cells and singly in suspension Cytogenic data: human flat-moded hypodiploid karyotype with 6% polyploidy - 41(40-43)< 2n> XY, -3, -13, -16, -19, -21, -22, +2mar, ins(X; 13)(p11; q?q?), del(3)(p13p24), add(5)(q11), dup(5)(q11q35), der(6)add(6)(p23)dup(6)(q25q27), der(7)add(7)(p13)add(7)(q12), add(9)(q35), der(9)del(9)(q11q34)inv(9)(p2?4; q34), der(10)t(8; 10)(q24; p14)t(10; 7)(q25; q12), del(11)(q14q21), der(21)t(10; 21)(p14; p12) - sideline with dup(1)(p35p36), dup(2)(q1?q2?), del(3)(p13p24) - matches published karyotype Patient: Male, 68 yrs of age Medium: RPMI-1640 Medium + 20% FBS + 10 ng/mL GM-CSF or 5 ng/mL rh IL-3 Subculture:Subculture saturated culture 1:3 to 1:8 every 2-5 days; seed out at ca. 0.3-0.5 x 10^6 cells/ml; maintain at ca. 1.0 x 10^6 cells/ml; maximum density at ca. 1.8 x 10^6 cells/ml. Upon cytokine withdrawal cells do not die but undergo a stationary survival status. REMARKS: by favoring selective growth, suboptimal culture of cytokine-dependent cell lines may promote growth of factor-independent subclones. Selective conditions include cytokine insufficiency and inadequate cell density. Therefore, we cannot guarantee indefinite stability of factor-dependence of cell lines. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 7.5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
human flat-moded hypodiploid karyotype with 6% polyploidy - 41(40-43)< 2n> XY, -3, -13, -16, -19, -21, -22, +2mar, ins(X; 13)(p11; q?q?), del(3)(p13p24), add(5)(q11), dup(5)(q11q35), der(6)add(6)(p23)dup(6)(q25q27), der(7)add(7)(p13)add(7)(q12), add(9)(q35), der(9)del(9)(q11q34)inv(9)(p2?4; q34), der(10)t(8; 10)(q24; p14)t(10; 7)(q25; q12), del(11)(q14q21), der(21)t(10; 21)(p14; p12) - sideline with dup(1)(p35p36), dup(2)(q1?q2?), del(3)(p13p24) - matches published karyotype Patient: Male, 68 yrs of age Medium: RPMI-1640 Medium + 20% FBS + 10 ng/mL GM-CSF or 5 ng/mL rh IL-3 Subculture:Subculture saturated culture 1:3 to 1:8 every 2-5 days; seed out at ca. 0.3-0.5 x 10^6 cells/ml; maintain at ca. 1.0 x 10^6 cells/ml; maximum density at ca. 1.8 x 10^6 cells/ml. Upon cytokine withdrawal cells do not die but undergo a stationary survival status. REMARKS: by favoring selective growth, suboptimal culture of cytokine-dependent cell lines may promote growth of factor-independent subclones. Selective conditions include cytokine insufficiency and inadequate cell density. Therefore, we cannot guarantee indefinite stability of factor-dependence of cell lines. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 7.5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
Male, 68 yrs of age Medium: RPMI-1640 Medium + 20% FBS + 10 ng/mL GM-CSF or 5 ng/mL rh IL-3 Subculture:Subculture saturated culture 1:3 to 1:8 every 2-5 days; seed out at ca. 0.3-0.5 x 10^6 cells/ml; maintain at ca. 1.0 x 10^6 cells/ml; maximum density at ca. 1.8 x 10^6 cells/ml. Upon cytokine withdrawal cells do not die but undergo a stationary survival status. REMARKS: by favoring selective growth, suboptimal culture of cytokine-dependent cell lines may promote growth of factor-independent subclones. Selective conditions include cytokine insufficiency and inadequate cell density. Therefore, we cannot guarantee indefinite stability of factor-dependence of cell lines. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 7.5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
RPMI-1640 Medium + 20% FBS + 10 ng/mL GM-CSF or 5 ng/mL rh IL-3 Subculture:Subculture saturated culture 1:3 to 1:8 every 2-5 days; seed out at ca. 0.3-0.5 x 10^6 cells/ml; maintain at ca. 1.0 x 10^6 cells/ml; maximum density at ca. 1.8 x 10^6 cells/ml. Upon cytokine withdrawal cells do not die but undergo a stationary survival status. REMARKS: by favoring selective growth, suboptimal culture of cytokine-dependent cell lines may promote growth of factor-independent subclones. Selective conditions include cytokine insufficiency and inadequate cell density. Therefore, we cannot guarantee indefinite stability of factor-dependence of cell lines. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 7.5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
Subculture saturated culture 1:3 to 1:8 every 2-5 days; seed out at ca. 0.3-0.5 x 10^6 cells/ml; maintain at ca. 1.0 x 10^6 cells/ml; maximum density at ca. 1.8 x 10^6 cells/ml. Upon cytokine withdrawal cells do not die but undergo a stationary survival status. REMARKS: by favoring selective growth, suboptimal culture of cytokine-dependent cell lines may promote growth of factor-independent subclones. Selective conditions include cytokine insufficiency and inadequate cell density. Therefore, we cannot guarantee indefinite stability of factor-dependence of cell lines. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 7.5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
Complete culture medium supplemented with 7.5% (v/v) DMSO
I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
Amelogenin: X, Y CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
CSF1PO: 9 D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
D13S317: 10 D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
D16S539: 10, 12 D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
D5S818:13 D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
D7S820: 9, 11 THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
THO1:8 TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
TPOX: 9, 11 vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
vWA: 14, 16 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.
Arbeitsanleitung (Data Sheet) anfordern
Produkt-Datenblatt anfordern
Sicherheitsdatenblatt anfordern
Vergleichen
Auf den Wunschzettel
Angebot anfordern
Lieferzeit anfragen
Technische Frage stellen
Bulk-Anfrage stellen
sales@hoelzel.de
« Zurück
Pünktliche Lieferung zu Ihrem Wunschtermin und bei jeder 5. Bestellung 15% sparen.
Passwort vergessen?
Noch nicht registriert? Konto hier erstellen!